APO RESEARCH · REPORT
Peanut Allergy Therapeutics
Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.
Product & engineering
Understand the product.
Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.
Selected research
Industry Research
Peanut Allergy Therapeutics Industry Research Report 2026
Market perspective
Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.
United States is the largest consumption place, with a consumption market share nearly 45% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Mylan, Bayer, UCB Pharma, J & J, Perrigo,top 5 players took 52% market share.
Read the full market overview
Report Scope
This report quantifies the global Peanut Allergy Therapeutics market in terms of revenue (US$ million) and, where applicable, service volume (M USD), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/M USD) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Peanut Allergy Therapeutics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Peanut Allergy Therapeutics Market by Company
Mylan
Bayer
UCB Pharma
J & J
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
HUAPONT Pharm
Allergy Therapeutics
ASIT Biotech
Sanofi
DBV Technologies
HAL Allergy
Intrommune Therapeutics
Peanut Allergy Therapeutics Segment by Type
Epinephrine Injection
Antihistamines
Oral Immunotherapy
Other
Peanut Allergy Therapeutics Segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Other
Peanut Allergy Therapeutics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peanut Allergy Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peanut Allergy Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peanut Allergy Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Peanut Allergy Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Epinephrine Injection
- Antihistamines
- Oral Immunotherapy
- Other
Applications
- Hospital Pharmacy
- Retail Pharmacy
- Other
Companies covered
- Mylan
- Bayer
- UCB Pharma
- J & J
- Perrigo
- GSK
- Kaleo
- Amneal Pharma
- ALK Abello
- Aimmune Therapeutics
- HUAPONT Pharm
- Allergy Therapeutics
- ASIT Biotech
- Sanofi
- DBV Technologies
- HAL Allergy
- Intrommune Therapeutics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Peanut Allergy Therapeutics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Epinephrine Injection
- 2.2.3 Antihistamines
- 2.2.4 Oral Immunotherapy
- 2.2.5 Other
- 2.3 Peanut Allergy Therapeutics by Distribution Channel
- 2.3.1 Market Value Comparison by Distribution Channel (2021 VS 2025 VS 2032)
- 2.3.2 Hospital Pharmacy
- 2.3.3 Retail Pharmacy
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Peanut Allergy Therapeutics Breakdown Data by Type
- 3.1 Global Peanut Allergy Therapeutics Historic Market Size by Type (2021-2026)
- 3.2 Global Peanut Allergy Therapeutics Forecasted Market Size by Type (2027-2032)
4 Peanut Allergy Therapeutics Breakdown Data by Distribution Channel
- 4.1 Global Peanut Allergy Therapeutics Historic Market Size by Distribution Channel (2021-2026)
- 4.2 Global Peanut Allergy Therapeutics Forecasted Market Size by Distribution Channel (2027-2032)
5 Global Growth Trends
- 5.1 Global Peanut Allergy Therapeutics Market Perspective (2021-2032)
- 5.2 Global Peanut Allergy Therapeutics Growth Trends by Region
- 5.2.1 Global Peanut Allergy Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Peanut Allergy Therapeutics Historic Market Size by Region (2021-2026)
- 5.2.3 Peanut Allergy Therapeutics Forecasted Market Size by Region (2027-2032)
- 5.3 Peanut Allergy Therapeutics Market Dynamics
- 5.3.1 Peanut Allergy Therapeutics Industry Trends
- 5.3.2 Peanut Allergy Therapeutics Market Drivers
- 5.3.3 Peanut Allergy Therapeutics Market Challenges
- 5.3.4 Peanut Allergy Therapeutics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Peanut Allergy Therapeutics Players by Revenue
- 6.1.1 Global Top Peanut Allergy Therapeutics Players by Revenue (2021-2026)
- 6.1.2 Global Peanut Allergy Therapeutics Revenue Market Share by Players (2021-2026)
- 6.2 Global Peanut Allergy Therapeutics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Peanut Allergy Therapeutics Head Office and Area Served
- 6.4 Global Peanut Allergy Therapeutics Players, Product Type & Application
- 6.5 Global Peanut Allergy Therapeutics Manufacturers Established Date
- 6.6 Global Peanut Allergy Therapeutics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Peanut Allergy Therapeutics Market Size (2021-2032)
- 7.2 North America Peanut Allergy Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Peanut Allergy Therapeutics Market Size by Country (2021-2026)
- 7.4 North America Peanut Allergy Therapeutics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Peanut Allergy Therapeutics Market Size (2021-2032)
- 8.2 Europe Peanut Allergy Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Peanut Allergy Therapeutics Market Size by Country (2021-2026)
- 8.4 Europe Peanut Allergy Therapeutics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Peanut Allergy Therapeutics Market Size (2021-2032)
- 9.2 Asia-Pacific Peanut Allergy Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Peanut Allergy Therapeutics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Peanut Allergy Therapeutics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Peanut Allergy Therapeutics Market Size (2021-2032)
- 10.2 South America Peanut Allergy Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Peanut Allergy Therapeutics Market Size by Country (2021-2026)
- 10.4 South America Peanut Allergy Therapeutics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Peanut Allergy Therapeutics Market Size (2021-2032)
- 11.2 Middle East & Africa Peanut Allergy Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Mylan
- 12.1.1 Mylan Company Information
- 12.1.2 Mylan Business Overview
- 12.1.3 Mylan Revenue in Peanut Allergy Therapeutics Business (2021-2026)
- 12.1.4 Mylan Peanut Allergy Therapeutics Product Portfolio
- 12.1.5 Mylan Recent Developments
- 12.2 Bayer
- 12.2.1 Bayer Company Information
- 12.2.2 Bayer Business Overview
- 12.2.3 Bayer Revenue in Peanut Allergy Therapeutics Business (2021-2026)
- 12.2.4 Bayer Peanut Allergy Therapeutics Product Portfolio
- 12.2.5 Bayer Recent Developments
- 12.3 UCB Pharma
- 12.3.1 UCB Pharma Company Information
- 12.3.2 UCB Pharma Business Overview
- 12.3.3 UCB Pharma Revenue in Peanut Allergy Therapeutics Business (2021-2026)
- 12.3.4 UCB Pharma Peanut Allergy Therapeutics Product Portfolio
- 12.3.5 UCB Pharma Recent Developments
- 12.4 J & J
- 12.4.1 J & J Company Information
- 12.4.2 J & J Business Overview
- 12.4.3 J & J Revenue in Peanut Allergy Therapeutics Business (2021-2026)
- 12.4.4 J & J Peanut Allergy Therapeutics Product Portfolio
- 12.4.5 J & J Recent Developments
- 12.5 Perrigo
- 12.5.1 Perrigo Company Information
- 12.5.2 Perrigo Business Overview
- 12.5.3 Perrigo Revenue in Peanut Allergy Therapeutics Business (2021-2026)
- 12.5.4 Perrigo Peanut Allergy Therapeutics Product Portfolio
- 12.5.5 Perrigo Recent Developments
- 12.6 GSK
- 12.6.1 GSK Company Information
- 12.6.2 GSK Business Overview
- 12.6.3 GSK Revenue in Peanut Allergy Therapeutics Business (2021-2026)
- 12.6.4 GSK Peanut Allergy Therapeutics Product Portfolio
- 12.6.5 GSK Recent Developments
- 12.7 Kaleo
- 12.7.1 Kaleo Company Information
- 12.7.2 Kaleo Business Overview
- 12.7.3 Kaleo Revenue in Peanut Allergy Therapeutics Business (2021-2026)
- 12.7.4 Kaleo Peanut Allergy Therapeutics Product Portfolio
- 12.7.5 Kaleo Recent Developments
- 12.8 Amneal Pharma
- 12.8.1 Amneal Pharma Company Information
- 12.8.2 Amneal Pharma Business Overview
- 12.8.3 Amneal Pharma Revenue in Peanut Allergy Therapeutics Business (2021-2026)
- 12.8.4 Amneal Pharma Peanut Allergy Therapeutics Product Portfolio
- 12.8.5 Amneal Pharma Recent Developments
- 12.9 ALK Abello
- 12.9.1 ALK Abello Company Information
- 12.9.2 ALK Abello Business Overview
- 12.9.3 ALK Abello Revenue in Peanut Allergy Therapeutics Business (2021-2026)
- 12.9.4 ALK Abello Peanut Allergy Therapeutics Product Portfolio
- 12.9.5 ALK Abello Recent Developments
- 12.10 Aimmune Therapeutics
- 12.10.1 Aimmune Therapeutics Company Information
- 12.10.2 Aimmune Therapeutics Business Overview
- 12.10.3 Aimmune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2021-2026)
- 12.10.4 Aimmune Therapeutics Peanut Allergy Therapeutics Product Portfolio
- 12.10.5 Aimmune Therapeutics Recent Developments
- 12.11 HUAPONT Pharm
- 12.11.1 HUAPONT Pharm Company Information
- 12.11.2 HUAPONT Pharm Business Overview
- 12.11.3 HUAPONT Pharm Revenue in Peanut Allergy Therapeutics Business (2021-2026)
- 12.11.4 HUAPONT Pharm Peanut Allergy Therapeutics Product Portfolio
- 12.11.5 HUAPONT Pharm Recent Developments
- 12.12 Allergy Therapeutics
- 12.12.1 Allergy Therapeutics Company Information
- 12.12.2 Allergy Therapeutics Business Overview
- 12.12.3 Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2021-2026)
- 12.12.4 Allergy Therapeutics Peanut Allergy Therapeutics Product Portfolio
- 12.12.5 Allergy Therapeutics Recent Developments
- 12.13 ASIT Biotech
- 12.13.1 ASIT Biotech Company Information
- 12.13.2 ASIT Biotech Business Overview
- 12.13.3 ASIT Biotech Revenue in Peanut Allergy Therapeutics Business (2021-2026)
- 12.13.4 ASIT Biotech Peanut Allergy Therapeutics Product Portfolio
- 12.13.5 ASIT Biotech Recent Developments
- 12.14 Sanofi
- 12.14.1 Sanofi Company Information
- 12.14.2 Sanofi Business Overview
- 12.14.3 Sanofi Revenue in Peanut Allergy Therapeutics Business (2021-2026)
- 12.14.4 Sanofi Peanut Allergy Therapeutics Product Portfolio
- 12.14.5 Sanofi Recent Developments
- 12.15 DBV Technologies
- 12.15.1 DBV Technologies Company Information
- 12.15.2 DBV Technologies Business Overview
- 12.15.3 DBV Technologies Revenue in Peanut Allergy Therapeutics Business (2021-2026)
- 12.15.4 DBV Technologies Peanut Allergy Therapeutics Product Portfolio
- 12.15.5 DBV Technologies Recent Developments
- 12.16 HAL Allergy
- 12.16.1 HAL Allergy Company Information
- 12.16.2 HAL Allergy Business Overview
- 12.16.3 HAL Allergy Revenue in Peanut Allergy Therapeutics Business (2021-2026)
- 12.16.4 HAL Allergy Peanut Allergy Therapeutics Product Portfolio
- 12.16.5 HAL Allergy Recent Developments
- 12.17 Intrommune Therapeutics
- 12.17.1 Intrommune Therapeutics Company Information
- 12.17.2 Intrommune Therapeutics Business Overview
- 12.17.3 Intrommune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2021-2026)
- 12.17.4 Intrommune Therapeutics Peanut Allergy Therapeutics Product Portfolio
- 12.17.5 Intrommune Therapeutics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst